Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Immune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05389293
What this trial is testing

Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Who this might be right for
Follicular LymphomaLymphoma
Memorial Sloan Kettering Cancer Center 152
Large-scale testing (Phase 3)Ended earlyNCT02081183
What this trial is testing

Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 16
Not applicableUnknownNCT06449794
What this trial is testing

Neuropsycatric Disorders Among Children With Systemic Lupus Erythematosus in Sohag University Hospital

Who this might be right for
Systemic Lupus Erythematosus
Sohag University 50
Not applicableStudy completedNCT06629753
What this trial is testing

Differentiated Service Delivery for Pregnant and Postpartum Women Living With HIV and Their Infants

Who this might be right for
HivTransmission VerticalViremia+2 more
Indiana University 278
Testing effectiveness (Phase 2)Study completedNCT03770273
What this trial is testing

Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
National Institute of Allergy and Infectious Diseases (NIAID) 21
Not applicableStudy completedNCT00339703
What this trial is testing

Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic Inflammation and Disease State.

Who this might be right for
Asthma
59th Medical Wing 44
Not applicableUnknownNCT04046172
What this trial is testing

Treatment of Periodontal Disease in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusPeriodontitis
University College, London 200
Testing effectiveness (Phase 2)Study completedNCT00753103
What this trial is testing

Anti-Cytokine Therapy for Vasculitis

Who this might be right for
Wegener's GranulomatosisRenal Limited VasculitisMicroscopic Polyangiitis
University Hospital Birmingham NHS Foundation Trust 37
Not applicableLooking for participantsNCT06277427
What this trial is testing

Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells

Who this might be right for
Lupus NephritisANCA Associated Vasculitis
Lingli Dong 24
Early research (Phase 1)Study completedNCT00003294
What this trial is testing

Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Roswell Park Cancer Institute 24
Not applicableStudy completedNCT04891146
What this trial is testing

The Effect of Anesthesia on Systemic Inflammatory Immune Index in Major Abdominal Cancer Surgeries

Who this might be right for
Systemic Immune ActivationCancer GiCancer of Endometrium
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital 84
Very early researchLooking for participantsNCT07274059
What this trial is testing

Allogeneic UCB-derived CAR-T for SLE

Who this might be right for
SLE - Systemic Lupus Erythematosus
Chengdu Ucello Biotechnology Co., Ltd. 48
Testing effectiveness (Phase 2)Study completedNCT01405196
What this trial is testing

Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Pfizer 183
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06888973
What this trial is testing

Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases

Who this might be right for
Rheumatoid ArthritisSystemic Lupus Erythematosus (SLE)Systemic Sclerosis+3 more
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 200
Testing effectiveness (Phase 2)Ended earlyNCT05430854
What this trial is testing

Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study

Who this might be right for
Systemic Lupus Erythematosus
Amgen 155
Not applicableStudy completedNCT02190929
What this trial is testing

Educational Needs of Patients With Systemic Vasculitis

Who this might be right for
Behcet's DiseaseChurg-Strauss SyndromeVasculitis, Central Nervous System+6 more
University of South Florida 386
Large-scale testing (Phase 3)Ended earlyNCT04181762
What this trial is testing

Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 275
Testing effectiveness (Phase 2)Study completedNCT00006251
What this trial is testing

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more
Fred Hutchinson Cancer Center 21
Early research (Phase 1)UnknownNCT05978661
What this trial is testing

FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Who this might be right for
Light Chain Amyloidosis
Nanjing University School of Medicine 12
Testing effectiveness (Phase 2)Study completedNCT05197842
What this trial is testing

Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis

Who this might be right for
ANCA-associated Vasculitis
Staidson (Beijing) Biopharmaceuticals Co., Ltd 93
Next Page